![Josie Yang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Josie Yang
Nessuna posizione attualmente
Profilo
Josie Yang worked as Vice President & Head-Global Regulatory Strategy at PTC Therapeutics, Inc., Vice President & Head-Regulatory Affairs at Avrobio, Inc., and Associate Vice President-Global Regulatory Affairs at ImClone Systems Corp.
Dr. Yang holds a doctorate degree from Auburn University and National Taiwan University.
Precedenti posizioni note di Josie Yang
Società | Posizione | Fine |
---|---|---|
PTC THERAPEUTICS, INC. | Corporate Officer/Principal | - |
ImClone Systems Corp. | Consigliere Generale | - |
TECTONIC THERAPEUTIC, INC. | Public Communications Contact | - |
Formazione di Josie Yang
Auburn University | Doctorate Degree |
National Taiwan University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Società collegate
Società quotate in Borsa | 1 |
---|---|
PTC THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Avrobio, Inc.
![]() Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |
ImClone Systems Corp. | Health Technology |
- Borsa valori
- Insiders
- Josie Yang